RAE E RINGENBERG

Allopathic & Osteopathic Physicians|Family Medicine APOPKA, FL NPI 1477500494

General Payments — all program years on this page

$6,066.72

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 67
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $989.72 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $978.1610
Education $11.561

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $254.923
GlaxoSmithKline, LLC. $243.253
Lilly USA, LLC $227.022
ABBVIE INC. $125.001
Novo Nordisk AS $112.001
Abbott Laboratories $27.531

By program year

Program yearAmountRecords
2018 $1,353.1116
2019 $928.5010
2020 $614.146
2021 $389.464
2022 $589.136
2023 $1,202.6614
2024 $989.7211

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097525275 Novo Nordisk Inc $112.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105296107 AstraZeneca Pharmaceuticals LP $118.36 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105388711 AstraZeneca Pharmaceuticals LP $125.00 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105606575 AstraZeneca Pharmaceuticals LP $11.56 05/29/2024 Education Undisputed 01/23/2026 View at CMS
1105950997 ABBVIE INC. $125.00 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116342872 GlaxoSmithKline, LLC. $112.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116363599 GlaxoSmithKline, LLC. $6.26 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116689545 GlaxoSmithKline, LLC. $124.99 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125083291 Abbott Laboratories $27.53 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135300779 Lilly USA, LLC $111.37 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135330050 Lilly USA, LLC $115.65 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.